Trial intelligence / Profile preview

Prophylactic ondansetron plus phenylephrine versus placebo plus phenylephrine for hemodynamic stability after spinal anesthesia in cesarean section

TCTR20221001007Phase 4Completed

Sponsor
N/A
Start
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ondansetron in hypotension, bradyarrhythmia, sponsored by N/A. Started Jan 2023; status: completed.

02

Drugs

ondansetron
03

Conditions

hypotensionbradyarrhythmia

Beyond the preview

Go deeper on TCTR20221001007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20221001007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call